Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Despite tariff fears European stocks have outperformed Wall Street this year. Here's why UBS thinks that will continue.
In addition, further weakness in the euro - UBS sees it falling to $0.99 by the end of 2025 - would be consistent with improving earnings revisions. A 10% fall in the euro may increase European ...
Why I'm Cautious On Rocket Lab Despite Its Strong Growth Story
Rocket Lab's revenue grew 55% YoY, but mounting losses raise concerns. Discover fair valuation insights and strategic ...
Leveraging Generative AI In Supply Chain Risk Assessment And Mitigation
• Greater Collaboration Across the Supply Chain: Generative AI can enhance collaboration among suppliers, logistics providers ...
University of Oslo12h
TEK5340 – Energy Systems Analysis: Modelling, Methods and Scenarios
The course provides a comprehensive overview of energy system analysis, a discipline that gives insights into how energy systems can be designed and operated to cover future energy needs in a ...